Green's child and adolescent clinical psychopharmacology
Author(s)
Bibliographic Information
Green's child and adolescent clinical psychopharmacology
Wolters Kluwer Health/Lippincott Williams & Wilkins, c2014
5th ed
- : [pbk.]
Available at 3 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Other authors: Rick Bowers, Christina Weston, Julia Jackson
Includes bibliographical references (p. 361-399) and index
Description and Table of Contents
Description
The ideal quick reference for the busy mental health clinician seeing younger patients, the Fifth Edition of Green's Child and Adolescent Clinical Psychopathology has been fully revised by a new team of authors active in clinical practice and resident education. A trusted reference in the field, Green's continues to provide practical and balanced information on the full range of medications used to treat mental health disorders in children and adolescents.
This rapid reference delivers...
* Detailed coverage of medication usage -including both FDA-approved and evidence-based off-label uses.
* Precautions and warnings help readers avoid prescribing errors and adverse drug interactions.
* Emphasis on recent and highly used medications, with older and less often used agents grouped in an Appendix.
* Convenient, reader-friendly organization makes essential information easy to find and use.
NEW to the Fifth Edition...
* Increased focus on medication effects and cost-effectiveness
* New information on cardiac function and risk factors in patients taking stimulants
* Long-term suicide risks associated with SSRIs
* Longer term outcomes of major depression treatment
* Use of anticonvulsant medications in patients with bipolar disorder
* Weight gain in patients taking antipsychotics
by "Nielsen BookData"